Hikari Power LTD Raised Synergy Pharmaceuticals (SGYP) Holding By $800,000; Zagg (ZAGG) Shorts Increased By 4.46%

ZAGG Inc (NASDAQ:ZAGG) Logo

Zagg Inc (NASDAQ:ZAGG) had an increase of 4.46% in short interest. ZAGG’s SI was 1.72M shares in April as released by FINRA. Its up 4.46% from 1.64M shares previously. With 788,900 avg volume, 2 days are for Zagg Inc (NASDAQ:ZAGG)’s short sellers to cover ZAGG’s short positions. The SI to Zagg Inc’s float is 6.43%. The stock decreased 3.75% or $0.45 during the last trading session, reaching $11.55. About 306,441 shares traded. ZAGG Inc (NASDAQ:ZAGG) has risen 88.37% since April 10, 2017 and is uptrending. It has outperformed by 76.82% the S&P500.

Hikari Power Ltd increased Synergy Pharmaceuticals Inc (SGYP) stake by 26.67% reported in 2017Q4 SEC filing. Hikari Power Ltd acquired 400,000 shares as Synergy Pharmaceuticals Inc (SGYP)’s stock declined 21.49%. The Hikari Power Ltd holds 1.90M shares with $4.24M value, up from 1.50 million last quarter. Synergy Pharmaceuticals Inc now has $463.72M valuation. The stock decreased 0.53% or $0.01 during the last trading session, reaching $1.88. About 3.60M shares traded. Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has declined 62.55% since April 10, 2017 and is downtrending. It has underperformed by 74.10% the S&P500.

Among 8 analysts covering Synergy Pharmaceuticals (NASDAQ:SGYP), 6 have Buy rating, 1 Sell and 1 Hold. Therefore 75% are positive. Synergy Pharmaceuticals has $20 highest and $2.5 lowest target. $9.39’s average target is 399.47% above currents $1.88 stock price. Synergy Pharmaceuticals had 42 analyst reports since August 25, 2015 according to SRatingsIntel. Roth Capital reinitiated the shares of SGYP in report on Thursday, October 29 with “” rating. The stock of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has “Sell” rating given on Thursday, April 6 by Citigroup. Cantor Fitzgerald maintained Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) on Wednesday, September 27 with “Buy” rating. The firm has “Buy” rating by H.C. Wainwright given on Thursday, August 10. The firm earned “Buy” rating on Monday, June 26 by BTIG Research. Cantor Fitzgerald maintained the stock with “Buy” rating in Wednesday, August 9 report. As per Monday, May 9, the company rating was maintained by Rodman & Renshaw. Oppenheimer maintained it with “Buy” rating and $6.0 target in Tuesday, October 10 report. As per Monday, January 22, the company rating was maintained by Oppenheimer. The firm earned “Buy” rating on Thursday, August 10 by Oppenheimer.

Investors sentiment decreased to 1.22 in 2017 Q4. Its down 0.68, from 1.9 in 2017Q3. It dropped, as 21 investors sold SGYP shares while 34 reduced holdings. 24 funds opened positions while 43 raised stakes. 125.65 million shares or 14.56% less from 147.06 million shares in 2017Q3 were reported. Wells Fargo And Mn holds 0% of its portfolio in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) for 163,657 shares. Rhumbline Advisers invested in 0% or 217,593 shares. Trellus Mngmt Ltd holds 0.34% or 112,500 shares. Ingalls And Snyder Ltd Liability Corp accumulated 0% or 10,000 shares. Malaga Cove Cap Limited Liability Company has invested 0.12% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Moreover, Cambridge Research Advsrs Inc has 0% invested in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) for 39,150 shares. Oz Management Lp invested in 0% or 444,200 shares. Citigroup Inc holds 2.34M shares or 0% of its portfolio. 1.90 million are owned by Hikari Power Limited. Bnp Paribas Arbitrage owns 56,937 shares or 0% of their US portfolio. Morgan Stanley accumulated 1.38 million shares. Ing Groep Nv holds 0% or 17,500 shares in its portfolio. Sei Invs Com invested in 0% or 773 shares. Nantahala Capital Mngmt Lc has invested 0.69% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Warren Averett Asset Ltd Liability Company has invested 0% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP).

Investors sentiment increased to 1.38 in 2017 Q4. Its up 0.11, from 1.27 in 2017Q3. It improved, as 17 investors sold ZAGG Inc shares while 39 reduced holdings. 41 funds opened positions while 36 raised stakes. 21.35 million shares or 2.50% less from 21.90 million shares in 2017Q3 were reported. Stone Ridge Asset Ltd Liability Co accumulated 38,244 shares. Goldman Sachs Gp holds 0% or 126,038 shares in its portfolio. Ser Automobile Association has invested 0.01% in ZAGG Inc (NASDAQ:ZAGG). State Street owns 454,731 shares. Citigroup invested 0% of its portfolio in ZAGG Inc (NASDAQ:ZAGG). Art Limited Liability Com holds 0.12% of its portfolio in ZAGG Inc (NASDAQ:ZAGG) for 145,904 shares. Walleye Trading Ltd Liability owns 7,065 shares. D E Shaw & holds 0% or 70,753 shares. Credit Suisse Ag owns 21,123 shares or 0% of their US portfolio. Lazard Asset Mngmt Lc has invested 0% in ZAGG Inc (NASDAQ:ZAGG). Blackrock accumulated 1.81M shares or 0% of the stock. California Pub Employees Retirement Systems owns 0% invested in ZAGG Inc (NASDAQ:ZAGG) for 159,794 shares. Pacific Ridge Capital Prtnrs Ltd Limited Liability Company holds 167,681 shares or 0.82% of its portfolio. Atlantic Tru Grp Lc invested in 0% or 400 shares. Morgan Stanley invested in 81,575 shares.

ZAGG Inc (NASDAQ:ZAGG) Institutional Positions Chart